EveryONE Medicines

📍 Boston, United States🗓 Founded 2020👥 12 employees💰 Last funded Sep 2022
Biotechnology Research🌐 everyonemedicines.com
Website LinkedIn
EveryONE Medicines is committed to developing individualized precision medicines targeting genetic variants causing fatal, neurodegenerative diseases unique to just a few or even ONE patient. Momentum is building as technological advances with genomic testing and the prevalence of testing is improving rapidly to identify the rarest of rare mutations. Through a collaborative effort across all stakeholders in the treatment and diagnosis of rare genetic disease, EveryONE Medicines will bring a scalable solution to meet the needs of the individual patient who currently has limited hope.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in EveryONE Medicines?
EveryONE Medicines has 1 investors on record on gritt.io, including 1 early-stage backers.
When did EveryONE Medicines last raise funding?
The most recent investment in EveryONE Medicines recorded on gritt.io was in September 2022.
When was EveryONE Medicines founded?
EveryONE Medicines was founded in 2020.
What industry is EveryONE Medicines in?
EveryONE Medicines operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is EveryONE Medicines based?
EveryONE Medicines is headquartered in Boston, United States.